158 related articles for article (PubMed ID: 27560502)
1. The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
Malo CS; Renner DN; Huseby Kelcher AM; Jin F; Hansen MJ; Pavelko KD; Johnson AJ
PLoS One; 2016; 11(8):e0162064. PubMed ID: 27560502
[TBL] [Abstract][Full Text] [Related]
2. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
[TBL] [Abstract][Full Text] [Related]
3. Conditional Silencing of H-2D
Tritz ZP; Orozco RC; Malo CS; Ayasoufi K; Fain CE; Khadka RH; Goddery EN; Yokanovich LT; Settell ML; Hansen MJ; Jin F; Pavelko KD; Pease LR; Johnson AJ
J Immunol; 2020 Sep; 205(5):1228-1238. PubMed ID: 32737149
[TBL] [Abstract][Full Text] [Related]
4. Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28.
Johnson AJ; Njenga MK; Hansen MJ; Kuhns ST; Chen L; Rodriguez M; Pease LR
J Virol; 1999 May; 73(5):3702-8. PubMed ID: 10196262
[TBL] [Abstract][Full Text] [Related]
5. A translatable molecular approach to determining CD8 T-cell epitopes in TMEV infection.
McDole J; Suidan G; Boespflug E; Cheng J; Chen Y; Pirko I; Johnson A
Hum Immunol; 2008 Nov; 69(11):805-10. PubMed ID: 18817825
[TBL] [Abstract][Full Text] [Related]
6. Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique.
Cumba Garcia LM; Huseby Kelcher AM; Malo CS; Johnson AJ
J Immunol Methods; 2016 Dec; 439():23-28. PubMed ID: 27623324
[TBL] [Abstract][Full Text] [Related]
7. The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.
Pavelko KD; Bell MP; Karyampudi L; Hansen MJ; Allen KS; Knutson KL; Pease LR
Mol Ther; 2013 May; 21(5):1087-95. PubMed ID: 23568262
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus-Based Vaccine Expressing a Modified Tumor Antigen Induces Potent Tumor-Specific CD8(+) T-cell Response and Protects Mice from Melanoma.
Qiu Z; Huang H; Grenier JM; Perez OA; Smilowitz HM; Adler B; Khanna KM
Cancer Immunol Res; 2015 May; 3(5):536-46. PubMed ID: 25633711
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the Tumor Selectivity of a Picornavirus Virotherapy Promotes Tumor Regression and the Accumulation of Infiltrating CD8+ T Cells.
Bell MP; Pavelko KD
Mol Cancer Ther; 2016 Mar; 15(3):523-30. PubMed ID: 26823492
[TBL] [Abstract][Full Text] [Related]
12. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection.
Johnson AJ; Upshaw J; Pavelko KD; Rodriguez M; Pease LR
FASEB J; 2001 Dec; 15(14):2760-2. PubMed ID: 11606479
[TBL] [Abstract][Full Text] [Related]
13. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice.
Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS
Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014
[TBL] [Abstract][Full Text] [Related]
14. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Yamanaka R; Xanthopoulos KG
DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
[TBL] [Abstract][Full Text] [Related]
15. A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.
Bell MP; Renner DN; Johnson AJ; Pavelko KD
Viral Immunol; 2014 Sep; 27(7):361-6. PubMed ID: 25025983
[TBL] [Abstract][Full Text] [Related]
16. Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy.
Medrano RF; Catani JP; Ribeiro AH; Tomaz SL; Merkel CA; Costanzi-Strauss E; Strauss BE
Cancer Immunol Immunother; 2016 Apr; 65(4):371-82. PubMed ID: 26887933
[TBL] [Abstract][Full Text] [Related]
17. Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler's virus infection.
Mendez-Fernandez YV; Hansen MJ; Rodriguez M; Pease LR
J Virol; 2005 Mar; 79(5):3063-70. PubMed ID: 15709026
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
Prins RM; Odesa SK; Liau LM
Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
[TBL] [Abstract][Full Text] [Related]
19. The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.
Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Sep; 16(9):1609-16. PubMed ID: 18612271
[TBL] [Abstract][Full Text] [Related]
20. Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma.
Brinkman M; Walter J; Grein S; Thies MJ; Schulz TW; Herrmann M; Reiser CO; Hess J
Cancer Immunol Immunother; 2005 Jun; 54(6):611-22. PubMed ID: 15685447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
